Researchers at the University of Copenhagen have identified a promising new drug target for weight loss which could revolutionise treatment for millions of people with obesity and type 2 diabetes. The ...

Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, increases energy expenditure, and improves insulin sensitivity without causing nausea or ...

millaf – stock.adobe.com Ozempic is part of a class of diabetes and obesity drugs that mimic the GLP-1 hormone the body ...

Researchers believe discovery will springboard research to make more tolerable, effective weight loss treatments accessible ...

Stopping semaglutide, marketed as Wegovy and Ozempic, which helps people lose weight , can have severe health impacts, a new ...

A study published Wednesday suggests a surprising side effect of GLP-1 drugs such as Ozempic: they can be effective at ...

Hims & Hers (HIMS) has launched an online GLP-1 supply tracker where people can share information about where the popular ...

Hims & Hers Health on Wednesday launched a tracker for popular weight-loss and diabetes drugs that allows patients to share details about their challenges finding treatments such as Novo Nordisk's ...

A new weight loss drug target may help reduce appetite and burn calories without causing sickness, research suggests. The ...

There's new data suggesting that diabetes and weight-loss meds like Ozempic and ... people with alcohol use disorder who took ...